Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib

Leiomyosarcoma (LMS) is characterized by high genomic complexity, and to date, no specific targeted therapy is available. In a genome-wide approach, we profiled genomic aberrations in a small cohort of eight primary tumours, two relapses, and eight metastases across nine different patients. We ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Böhm, Michael J., Marienfeld, Ralf, Jäger, Daniela, Mellert, Kevin, von Witzleben, Adrian, Brüderlein, Silke, Wittau, Mathias, von Baer, Alexandra, Schultheiss, Markus, Mayer-Steinacker, Regine, Rücker, Frank G., Möller, Peter, Bullinger, Lars, Barth, Thomas F. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360577/
https://www.ncbi.nlm.nih.gov/pubmed/30804704
http://dx.doi.org/10.1155/2019/3914232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360577/
https://www.ncbi.nlm.nih.gov/pubmed/30804704
http://dx.doi.org/10.1155/2019/3914232

Ejemplares similares